CrAg screening strategy reduces definitive sequelae in people living with HIV
Abstract Background Screenning cryptococcal antigen (CrAg) of people living with HIV (PLHIV) reduces the morbidity and development of cryptococcal meningitis, but recent publications shows that it does not reduce mortality when comparable with a negative CrAg population group. Furthermore, most arti...
Saved in:
| Main Authors: | Marcela de Faria Ferreira, Fabio Brito-Santos, Marcos de Abreu Almeida, Luciana Trilles, Marcia dos Santos Lazera |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2025-06-01
|
| Series: | Discover Viruses |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s44370-025-00020-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An atypical presentation of immune reconstitution inflammatory syndrome (IRIS) in a patient with cryptococcal meningitis in the setting of fingolimod therapy for multiple sclerosis
by: Henco Nel, et al.
Published: (2025-01-01) -
Primary cutaneous cryptococcosis - History, concepts, clinical and therapeutic update
by: Sílvio Alencar Marques, et al.
Published: (2025-03-01) -
Evaluation of low cryptococcal antigen titer as determined by the lateral flow assay in serum and cerebrospinal fluid among HIV-negative patients: a retrospective diagnostic accuracy study
by: Xuan Wang, et al.
Published: (2020-03-01) -
Induction Treatment for HIV-Associated Cryptococcal Meningitis: Where Have We Been and Where Are We Going?
by: Dominique Milsap, et al.
Published: (2025-04-01) -
Fatores prognósticos da meningoencefalite criptocócica Prognostic factors in cryptococcal meningoencephalitis
by: CALIL DARZÉ, et al.
Published: (1999-09-01)